Shoulder Innovations Inc
NYSE:SI
Shoulder Innovations Inc
Shoulder Innovations Inc is a US-based company operating in industry. The company is headquartered in Grand Rapids, Michigan and currently employs 61 full-time employees. The company went IPO on 2025-07-31. Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The firm offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
Shoulder Innovations Inc is a US-based company operating in industry. The company is headquartered in Grand Rapids, Michigan and currently employs 61 full-time employees. The company went IPO on 2025-07-31. Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The firm offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
